PTBP1 and cancer: Our previous study reports that linc-RoR inhibits p53 translation by interacting with heterogeneous nuclear ribonucleoprotein I (hnRNP I) in response to DNA damage [17], and further studies suggest a link between linc-RoR and oncogene c-Myc in cancer progression [18].